FDA Finds Pfizer-BioNTech COVID Vaccine Candidate Is 95% Effective

The transcript discusses the FDA's analysis of Pfizer's COVID-19 vaccine, highlighting its 95% efficacy after two doses and some protection after one dose. It explains the mRNA technology used in the vaccine and common side effects. The FDA's review process and emergency use authorization are detailed, along with the need for safety follow-ups. The transcript concludes with current COVID-19 statistics in the US.

What is the duration for which safety follow-ups will have to happen for the vaccine to get full FDA approval?

What is the current situation regarding COVID-19 hospitalizations in the US according to the latest numbers?